+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities and Strategies to 2032

  • PDF Icon

    Report

  • 340 Pages
  • June 2023
  • Region: Global
  • The Business Research Company
  • ID: 5849315
This report describes and explains the artificial intelligence (AI) in drug discovery market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global artificial intelligence (AI) in drug discovery market reached a value of nearly $1,042.3 million in 2022, having grown at a compound annual growth rate (CAGR) of 30.5% since 2017. The market is expected to grow from $1,042.3 million in 2022 to $3,739.2 million in 2027 at a rate of 29.1%. The market is then expected to grow at a CAGR of 25.7% from 2027 and reach $11,729.1 million in 2032.

Growth in the historic period resulted from growth in emerging markets, the rising prevalence of chronic diseases, the increased adoption of artificial intelligence (AI) for cost efficient drug discovery and the increasing strict quality regulations for drug manufacturers. Factors that negatively affected growth in the historic period were low healthcare access in developing countries, the shortage of skilled labor and the high failure rate of AI projects.

Going forward, the government support, the increasing healthcare expenditure and rising adoption of cloud-based applications and services will drive the growth. Factors that could hinder the growth of the artificial intelligence (AI) in drug discovery market in the future include the incompatible health IT infrastructure in many countries.

The artificial intelligence (AI) in drug discovery market is segmented by technology into context-aware processing, natural language processing, querying method and deep learning. The deep learning market was the largest segment of the artificial intelligence (AI) in drug discovery market segmented by technology, accounting for 33.9% of the total in 2022. Going forward, the deep learning segment is expected to be the fastest growing segment in the artificial intelligence (AI) in drug discovery market segmented by technology, at a CAGR of 29.12% during 2022-2027.

The artificial intelligence (AI) in drug discovery market is segmented by drug type into small molecules and large molecules. The small molecules market was the largest segment of the artificial intelligence (AI) in drug discovery market segmented by drug type, accounting for 63.2% of the total in 2022. Going forward, the large molecules segment is expected to be the fastest growing segment in the artificial intelligence (AI) in drug discovery market segmented by drug type, at a CAGR of 31.7% during 2022-2027.

The artificial intelligence (AI) in drug discovery market is segmented by therapeutic type into metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, anti-infective diseases, respiratory diseases and other therapeutics. The oncology market was the largest segment of the artificial intelligence (AI) in drug discovery market segmented by therapeutic type, accounting for 23.2% of the total in 2022. Going forward, the other therapeutics segment is expected to be the fastest growing segment in the artificial intelligence (AI) in drug discovery market segmented by therapeutic type, at a CAGR of 29.9% during 2022-2027.

The artificial intelligence (AI) in drug discovery market is segmented by end user into pharmaceutical companies, biopharmaceutical companies, academic and research institutes and other end-users. The pharmaceutical companies market was the largest segment of the artificial intelligence (AI) in drug discovery market segmented by end user, accounting for 50.2% of the total in 2022. Going forward, the biopharmaceutical companies segment is expected to be the fastest growing segment in the artificial intelligence (AI) in drug discovery market segmented by end user, at a CAGR of 32.4% during 2022-2027.

North America was the largest region in the artificial intelligence (AI) in drug discovery market, accounting for 41.9% of the total in 2022. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the artificial intelligence (AI) in drug discovery market will be South America and Asia-Pacific where growth will be at CAGRs of 37.6% and X35.8% respectively. These will be followed by Africa and Western Europe where the markets are expected to grow at CAGRs of 32.8% and 31.4% respectively.

The artificial intelligence (AI) in drug discovery market is highly concentrated, with a large number of small players. The top ten competitors in the market made up to 79.32% of the total market in 2021. IBM Corporation was the largest competitor with 32.27% share of the market, followed by Microsoft Corporation with 21.25%, NVIDIA Corporation with 11.90%, Exscientia with 3.28%, Alphabet with 2.85%, Atomwise Inc. with 1.89%, Insilico Medicine with 1.87%, Owkin Inc. with 1.66%, Xtalpi Inc with 1.33%, and Cloud Pharmaceuticals with 1.01%.

The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by technology will arise in the deep learning segment, which will gain $914.6 million of global annual sales by 2027. The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by drug type will arise in the small molecules segment, which will gain $1,559.8 million of global annual sales by 2027. The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by therapeutic type will arise in the oncology segment, which will gain $642.2 million of global annual sales by 2027. The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by end user will arise in the pharmaceutical company’s segment, which will gain $1,245.1 million of global annual sales by 2027. The artificial intelligence (AI) in drug discovery market size will gain the most in the USA at $700.4 million.

Market-trend-based strategies for the artificial intelligence (AI) in drug discovery market include integration of multi-omics data, use of AI in target selection, use of AI in drug screening, introduction of AI innovation labs, increasing investments and partnerships and collaborations.

Player-adopted strategies in the artificial intelligence (AI) in drug discovery market include enhancing operational capabilities through the launch of new solutions and strengthening business operations through strategic collaborations and partnerships.

To take advantage of the opportunities, the publisher recommends the artificial intelligence (AI) in drug discovery companies to focus on use of AI in drug screening, focus on use of ai in target selection, focus on integration of multi-omics data, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, focus on fast-growing therapeutic areas and continue to target fast-growing end-users.

Table of Contents

1. Executive Summary2. Table Of Contents3. List Of Figures4. List Of Tables5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Artificial Intelligence (AI) In Drug Discovery Market Definition And Segmentations
6.4. Market Segmentation By Technology
6.4.1. Context-Aware Processing
6.4.2. Natural Language Processing
6.4.3. Querying Method
6.4.4. Deep Learning
6.5. Market Segmentation By Drug Type
6.5.1. Small Molecules
6.5.2. Large Molecules
6.6. Market Segmentation By Therapeutic Type
6.6.1. Metabolic Diseases
6.6.2. Cardiovascular Disease
6.6.3. Oncology
6.6.4. Neurodegenerative Diseases
6.6.5. Respiratory Diseases
6.6.6. Anti-Infective Diseases
6.6.7. Other Therapeutics
6.7. Market Segmentation By End-User
6.7.1. Pharmaceutical Companies
6.7.2. Biopharmaceutical Companies
6.7.3. Academic And Research Institutes
6.7.4. Other End-Users
7. Major Market Trends
7.1. Integration of Multi-Omics Data
7.2. Increasing Investments
7.3. Use Of AI In Drug Screening
7.4. Use Of AI In Target Selection
7.5. Introduction Of AI Innovation Labs
7.6. Partnerships And Collaborations
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
8.2.1. Market Drivers 2017 - 2022
8.2.2. Market Restraints 2017 - 2022
8.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 - 2027
8.3.2. Market Restraints 2022 - 2027
9. Global Artificial Intelligence (AI) In Drug Discovery Market Segmentation
9.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10. Artificial Intelligence (AI) In Drug Discovery Market, Regional and Country Analysis
10.1. Global Artificial Intelligence (AI) In Drug Discovery Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Artificial Intelligence (AI) In Drug Discovery Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.4. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.13. China Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.14. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.15. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.16. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.19. India Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.20. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.21. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.22. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.25. Japan Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.26. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.31. Australia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.32. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.37. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.38. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.43. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.44. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.4. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.5. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
12.9. UK Market
12.10. UK Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.11. UK Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.12. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.17. Germany Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.18. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.23. France Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.24. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.25. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.26. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.4. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.5. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
13.9. Russia Market
13.10. Russia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.11. Russia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.12. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.4. North America Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.5. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.13. USA Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.14. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes And Duties
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.4. South America Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.5. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.11. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.12. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
16.4. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
16.5. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
17.4. Africa Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
17.5. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. IBM Corporation
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Microsoft Corporation
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. NVIDIA Corporation
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Exscientia plc
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Alphabet Inc
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers And Acquisitions
19.1. Recursion Pharmaceuticals Acquired Cyclica And Valence
19.2. BioNTech Acquired InstaDeep
19.3. Verseon Corporation Acquired Edammo
19.4. iBio Acquired Rubryc Therapeutics
19.5. Odyssey Therapeutics Acquired Rahko
19.6. Genentech Acquired Prescient Design
19.7. X-Chem Acquired Glamorous AI
19.8. Exscientia Acquired Austrian Company Allcyte
19.9. Relay Therapeutics Acquired ZebiAI
20. Opportunities And Strategies
20.1. Global Artificial Intelligence (AI) In Drug Discovery Market In 2027 - Countries Offering Most New Opportunities
20.2. Global Artificial Intelligence (AI) In Drug Discovery Market In 2027 - Segments Offering Most New Opportunities
20.3. Global Artificial Intelligence (AI) In Drug Discovery Market In 2027 - Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Artificial Intelligence (AI) In Drug Discovery Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. About the Publisher
22.5. Copyright and Disclaimer

Executive Summary

Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities and Strategies to 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in drug discovery market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest growing market for artificial intelligence (AI) in drug discovery? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (AI) in drug discovery market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider artificial intelligence (AI) in drug discovery market; and compares it with other markets.

The report covers the following chapters:

  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the artificial intelligence (AI) in drug discovery market.
  • Key Trends
Highlights the major trends shaping the global artificial intelligence (AI) in drug discovery market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
  • Market Segmentation
Contains the market values (2017-2032) and analysis for segment by technology, by drug type, by therapeutic type and by end-user in the market.
  • Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities and Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions and Recommendations
This section includes recommendations for artificial intelligence (AI) in drug discovery providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:

Markets Covered:

1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning
2) By Drug Type: Small Molecules; Large Molecules
3) By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Anti-Infective Diseases; Respiratory Diseases; Other Therapeutics
4) By End User: Pharmaceutical Companies; Biopharmaceutical Companies; Academic and Research Institutes; Other End-Users

Companies Mentioned: IBM Corporation; Microsoft Corporation; NVIDIA Corporation; Exscientia; Alphabet; Atomwise Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa.

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; artificial intelligence (AI) in drug discovery indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • IBM Corporation
  • Microsoft Corporation
  • NVIDIA Corporation
  • Exscientia
  • Alphabet
  • Atomwise Inc.

Methodology

Loading
LOADING...

Table Information